Lagoy, Jenica S.
HRN: 21-35-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2022
AMPICILLIN 250MG (VIAL)
05/23/2022
05/30/2022
IV
145 Mg
Q12
MSAF, Thinly
Waiting Final Action
Indication: Empiric Type of Infection: Disseminated Systemic InfectionUnspecified Sepsis Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes